chr18-10550210-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003826.3(NAPG):c.929G>A(p.Gly310Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000715 in 1,581,078 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000035 ( 1 hom. )
Consequence
NAPG
NM_003826.3 missense
NM_003826.3 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 8.48
Genes affected
NAPG (HGNC:7642): (NSF attachment protein gamma) This gene encodes soluble NSF attachment protein gamma. The soluble NSF attachment proteins (SNAPs) enable N-ethyl-maleimide-sensitive fusion protein (NSF) to bind to target membranes. NSF and SNAPs appear to be general components of the intracellular membrane fusion apparatus, and their action at specific sites of fusion must be controlled by SNAP receptors particular to the membranes being fused. The product of this gene mediates platelet exocytosis and controls the membrane fusion events of this process.[provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.38551447).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NAPG | NM_003826.3 | c.929G>A | p.Gly310Glu | missense_variant | 12/12 | ENST00000322897.11 | |
NAPG | XM_011525754.3 | c.1109G>A | p.Gly370Glu | missense_variant | 13/13 | ||
NAPG | XM_011525756.3 | c.683G>A | p.Gly228Glu | missense_variant | 10/10 | ||
NAPG | XM_017026063.3 | c.674G>A | p.Gly225Glu | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NAPG | ENST00000322897.11 | c.929G>A | p.Gly310Glu | missense_variant | 12/12 | 1 | NM_003826.3 | P1 | |
NAPG | ENST00000583367.1 | n.1309G>A | non_coding_transcript_exon_variant | 7/7 | 2 | ||||
NAPG | ENST00000580224.5 | c.*792G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 2 | ||||
NAPG | ENST00000580483.5 | c.*670G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
63
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000733 AC: 16AN: 218368Hom.: 0 AF XY: 0.0000586 AC XY: 7AN XY: 119448
GnomAD3 exomes
AF:
AC:
16
AN:
218368
Hom.:
AF XY:
AC XY:
7
AN XY:
119448
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000350 AC: 50AN: 1428752Hom.: 1 Cov.: 30 AF XY: 0.0000254 AC XY: 18AN XY: 709990
GnomAD4 exome
AF:
AC:
50
AN:
1428752
Hom.:
Cov.:
30
AF XY:
AC XY:
18
AN XY:
709990
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74492
GnomAD4 genome
AF:
AC:
63
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
10
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2022 | The c.929G>A (p.G310E) alteration is located in exon 12 (coding exon 12) of the NAPG gene. This alteration results from a G to A substitution at nucleotide position 929, causing the glycine (G) at amino acid position 310 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at